Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Reeves

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Annals of Pharmacotherapy|February 16, 2022
Outcomes and Management of Immune Checkpoint Inhibitor-Induced Hypothyroidism: A Retrospective AnalysisAllison L Phillips, David J Reeves
Journal of Pain & Palliative Care Pharmacotherapy|May 11, 2017
Continuous Intravenous Lidocaine Infusion for the Management of Pain Uncontrolled by Opioid MedicationsDavid J Reeves, Alexandra E Foster
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 31, 2019
Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measuresJoshua L Murdock, David J Reeves
The Annals of Pharmacotherapy|September 3, 2010
Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosisAnthony J Perissinotti, David J Reeves
Pharmacotherapy|November 21, 2017
Severe Hypoglycemia Caused by LenalidomideDaniel J Przybylski, Ruemu Birhiray, David J Reeves
The Annals of Pharmacotherapy|November 22, 2013
Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate eliminationEmily Bain, Ruemu E Birhiray, David J Reeves
Frontiers in Oncology|March 27, 2023
QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysisDavid J Reeves, Molly Russell, Vijay U Rao
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 22, 2016
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiencyDavid J Reeves, Lindsay M Saum, Ruemu Birhiray
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2023
Impact of diabetes (type 2) and glycemic control on health-related outcomes of patients receiving chemotherapy for non-metastatic breast cancer: a retrospective analysisAllison L Phillips, David J Reeves, Susan Storey
Frontiers in Oncology|March 14, 2025
Immune checkpoint Inhibitor related myocarditis reported through the FDA adverse event reporting system: pharmacovigilance trends in reporting and outcomesDavid J Reeves, Kevin Leffers, Vijay U Rao
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|February 16, 2022
Outcomes and Management of Immune Checkpoint Inhibitor-Induced Hypothyroidism: A Retrospective AnalysisAllison L Phillips, David J Reeves
Journal of Pain & Palliative Care Pharmacotherapy|May 11, 2017
Continuous Intravenous Lidocaine Infusion for the Management of Pain Uncontrolled by Opioid MedicationsDavid J Reeves, Alexandra E Foster
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 31, 2019
Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measuresJoshua L Murdock, David J Reeves
The Annals of Pharmacotherapy|September 3, 2010
Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosisAnthony J Perissinotti, David J Reeves
Pharmacotherapy|November 21, 2017
Severe Hypoglycemia Caused by LenalidomideDaniel J Przybylski, Ruemu Birhiray, David J Reeves
The Annals of Pharmacotherapy|November 22, 2013
Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate eliminationEmily Bain, Ruemu E Birhiray, David J Reeves
Frontiers in Oncology|March 27, 2023
QTc prolongation risk among patients receiving oral targeted antineoplastic medications: A real-world community-based oncology analysisDavid J Reeves, Molly Russell, Vijay U Rao
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 22, 2016
I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiencyDavid J Reeves, Lindsay M Saum, Ruemu Birhiray
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2023
Impact of diabetes (type 2) and glycemic control on health-related outcomes of patients receiving chemotherapy for non-metastatic breast cancer: a retrospective analysisAllison L Phillips, David J Reeves, Susan Storey
Frontiers in Oncology|March 14, 2025
Immune checkpoint Inhibitor related myocarditis reported through the FDA adverse event reporting system: pharmacovigilance trends in reporting and outcomesDavid J Reeves, Kevin Leffers, Vijay U Rao
Pageof 4